References
- Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986: 314(10): 614–9
- Zizic TM, Hungerford DS, Stevens MB. Ischemic bone necrosis in systemic lupus erythematosus. II. The early diagnosis of ischemic necrosis of bone. Medicine 1980: 59(2): 134–42
Suggested readings
- Kaell A, Shetty M, Lee BC, et al. The diversity of neurologic events in SLE: prospective. computerized tomography, and classification of 82 events in 71 patients. Arch Neurol 1986: 43: 273–6
- Kassan SS, Lockshin MD. Central nervous system lupus erythematosus: the need for classification. Arthritis Rheum 1979: 22(12): 1382–5
- Kimberly RP, Lockshin MD, Sherman RL, et al. ‘End-stage’ lupus nephritis: clinical course of and outcome on dialysis—experience with 39 patients. Medicine (Baltimore) 1981: 60(4): 277–87
- Kimberly RP, Lockshin MD, Sherman RL, et al. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med 1981: 70(4): 817–24
- Kimberly RP, Lockshin MD, Sherman RL, et al. Reversible “end-stage” lupus nephritis: analysis of patients able to discontinue dialysis. Am J Med 1983: 74(3): 361–8
- Kimberly RP, Sherman RL, Mooradian J, et al. Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration. Arthritis Rheum 1979: 22(3): 281–5
- Lockshin MD. Systemic lupus erythematosus: problems in management. Compr Ther 1982: 8(4): 7–10
- Lockshin MD. Vasculitis. Bull NY Acad Med 1979: 55(9): 867–73
- Sergent JS, Lockshin MD, Christian CL. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) 1976: 55(1): 1–18
- Sergent JS, Lockshin MD, Klempner MS, et al. Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. Am J Med 1975: 58(5): 644–54